Press Releases
Press Release
May 10, 2018
Leader Pelosi. I guess it is officially afternoon. Good afternoon everyone. It is an honor to be here with our colleagues, some of whom have served in the House and now are in the Senate, all of us – Democrats on both sides of the Capitol – coming together to discuss an issue of health and financial stability for America’s families. The unjust pricing of prescription drugs that families need are rising at unprecedented and astronomical rates while cost of living rises and wages stagnate.
Press Release
May 10, 2018
Washington, D.C. – Democratic Leader Nancy Pelosi held her weekly press conference today in the Capitol Visitor Center and responded to President Trump’s misguided decision to terminate U.S. participation in the Joint Comprehensive Plan of Action. Below are the Leader’s remarks:
Press Release
May 10, 2018
Washington, D.C. – Democratic Leader Nancy Pelosi joined the Congressional Black Caucus and President and CEO of the National Urban League, Marc Morial, for a press conference introducing the Jobs & Justice Act, omnibus legislation that would, if passed, increase the upward social mobility of Black families, and help ensure equal protection under the law. Below are the Leader’s remarks:
Press Release
May 10, 2018
Washington, DC – Today House and Senate Democrats outlined a recently released report that exposed the alarming trend of rising prescription drug prices under the Trump administration and called on President Trump to support Democrats’ “Better Deal” proposals to lower prescription drug prices. Under the Trump Administration, the 20 most prescribed drugs under Medicare Part D have seen an average annual 12 percent price hike, while 12 of those drugs saw price hikes of over 50 percent, and the remaining six drugs saw price hikes of 100 percent. Despite harsh campaign rhetoric denouncing the pharmaceutical industry, President Trump has done nothing but line the pockets of pharmaceutical company executives through his tax giveaway to the wealthiest Americans and largest corporations while drug prices continued to climb. Five of the largest pharmaceutical companies have invested their savings from the tax windfall on $45 billion dollars in new stock buyback programs to benefit shareholders instead of working to make prescription drugs more affordable for the public. The report also highlights how Trump’s failure to act on rising prescription drug prices has left millions of Americans struggling to afford essential medication, endangering both the health and financial well-being of American families.
Press Release
May 9, 2018
Washington, D.C. – Democratic Leader Nancy Pelosi joined House Democrats, Machinists Union International President Robert Martinez Jr. and hard-working machinists from across the country for a press event to highlight the broken promises of the #GOPTaxScam. Below are the Leader’s remarks:
Press Release
May 8, 2018
Washington, D.C. —Democratic Leader Nancy Pelosi joined individuals from the Center for American Progress, MomsRising and Food Research Action Center for a press event to protect SNAP [Supplemental Nutrition Assistance Program]. Below are the Leader’s remarks:
Press Release
May 8, 2018
Leader Pelosi. I didn’t realize I was going to be speaking next, I was just enjoying the children. And aren’t they adorable?
Press Release
May 8, 2018
Washington, DC —Democratic Leader Nancy Pelosi joined Tri-Caucus and Oversight Democrats for a press conference on the Trump Administration’s rushed decision to add an untested new question on citizenship to the 2020 Census despite concerns raised by the Census Bureau itself and numerous stakeholders. Below are the Leader’s remarks:
Press Release
May 8, 2018
Washington, D.C.— Democratic Leader Nancy Pelosi issued this statement after President Trump announced he would pull the United States out of the Joint Comprehensive Plan of Action:
Press Release
May 7, 2018
“After exploding the deficit with the GOP Tax Scam’s massive handouts to corporations and the top 1 percent, Republicans are trying to eliminate funding dedicated to children’s health.